Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
Some patients treated with nirmatrelvir-ritonavir have experienced rebound of COVID-19 infections and symptoms; however, data are scarce on whether viral rebound also occurs in patients with COVID-19 receiving or not receiving molnupiravir.To examine the incidence of viral rebound in patients with C...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | الإنجليزية |
| منشور في: |
2022
|
| الوصول للمادة أونلاين: | https://doi.org/10.1001/jamanetworkopen.2022.45086 https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2799218/wong_2022_oi_221276_1669731214.59609.pdf |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|